Business / Finance

RSS

Thoratec fourth quarter revenues increase 17% to $128.5 million

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2012.

5 Feb 2013

Mesa Laboratories third quarter revenues increase 18% to $11,361,000

Mesa Laboratories, Inc. today reported an 18 percent increase in revenues for the third quarter ended December 31, 2012.

5 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

BD first quarter revenues increase 3.7% to $1.90 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.90 billion for the first fiscal quarter ended December 31, 2012, representing an increase of 3.7 percent from the prior-year period, or 5.2 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 5 Feb 2013

Novian Health completes $11M funding round

Novian Health, developer of Novilase Breast Therapy, announced today that it has successfully completed a funding round totaling $11 million.

5 Feb 2013

Fabrinet second quarter total revenue increases 73.3% to $167.4 million

Fabrinet, a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced its financial results for the second quarter of fiscal 2013 ended December 28, 2012.

5 Feb 2013

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Gilead Sciences, Inc. announced today its results of operations for the fourth quarter and full year 2012.

5 Feb 2013

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2012.

From Luminex 4 Feb 2013

Life Technologies full year 2012 revenue increases 2% to $3.8 billion

Life Technologies Corporation today announced results for its fourth quarter for the year ended Dec. 31, 2012.

4 Feb 2013

Healthcare innovator invests $1.5 million in Vestec

Vestec, Inc. a leader in cutting-edge Artificial Intelligence technologies, today announced that they have secured a $1.5 million equity investment from V. Raman Kumar, founder and former CEO of MModal, the world's largest clinical documentation company and pioneer of voice-based medical transcription

4 Feb 2013

Facing a 'transition year,' Aetna's fourth-quarter profits are halved

The insurer's net income dropped 49 percent as higher medical costs squeezed the profit margin for the insurer.

3 Feb 2013

BGI extends cash tender offer to purchase all outstanding shares of Complete Genomics

BGI-Shenzhen announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics, Inc. to 12:00 midnight on Wednesday, February 6, 2013.

2 Feb 2013

Pharmacuetical companies eye orphan drugs as new revenue source

Drug companies are fond of saying that every patient counts, but in the world of orphan diseases, entire business plans are built around the idea. ... Development of these drugs is increasingly attractive to pharmaceutical companies, which are searching for new sources of revenue as sales of more traditional, mass-market drugs have been lost to generic competition.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

Acadia acquires Delta Medical Center

Acadia Healthcare Company, Inc. today announced the purchase of Delta Medical Center, a 243-bed hospital in Memphis, TN, with the majority of operating beds dedicated to acute inpatient psychiatric patients.

1 Feb 2013

Selway signs definitive agreement to enter into business combination with HCCA

Selway Capital Acquisition Corporation announced today that it has signed a definitive agreement to enter into a business combination with Healthcare Corporation of America, Inc. (HCCA), which is one of the fastest growing PBM's in the market.

31 Jan 2013

Major East Coast academic medical center acquires BSD-500 Hyperthermia System

BSD Medical Corporation announced today that a major East Coast academic medical center has purchased a BSD-500 Hyperthermia System (BSD-500).

31 Jan 2013

Span-America first quarter net income increases 21% to $1.4 million

Span-America Medical Systems, Inc. today reported higher sales and net income for the first quarter ended December 29, 2012.

31 Jan 2013

Affymetrix fourth quarter total revenue increases 2% to $84.4 million

Affymetrix, Inc., today reported its operating results for the three and twelve months ended December 31, 2012.

31 Jan 2013

DelMar announces second closing of $1.5M in private placement

DelMar Pharmaceuticals, Inc. today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 million. The total amount raised in the private placement is $6.9 million.

31 Jan 2013